Concepedia

Thomas Cummin

TC

6

Publications

743

Citations

6

H-Index

2017

Active since

Affiliations

University of Southampton(Current)

Cancer Research UK

University of Cambridge

University of Leeds

St James's University Hospital

Thomas Cummin is an author at University of Southampton specializing in medicine, molecular diagnostics, and pathology.

Top concepts

Publications per year

2017–2020

6

Publications

6

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

Chulin Sha, Sharon Barrans, Francesco Cucco et al. · Journal of Clinical Oncology · 2018 · 291 citations · Full text

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial

Andrew Davies, Thomas Cummin, Sharon Barrans et al. · The Lancet Oncology · 2019 · 260 citations · Full text

Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit

Francesco Cucco, Sharon Barrans, Chulin Sha et al. · Leukemia · 2019 · 115 citations · Full text

BET inhibitors synergize with venetoclax to induce apoptosis in MYC-driven lymphomas with high BCL-2 expression

Thomas Cummin, Kerry L. Cox, Tom Murray et al. · Blood Advances · 2020 · 46 citations · Full text

DIFFERENTIAL EFFICACY OF BORTEZOMIB IN SUBTYPES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBL): a PROSPECTIVE RANDOMISED STUDY STRATIFIED BY TRANSCRIPTOME PROFILING: REMODL‐B

Andrew Davies, Sharon Barrans, Tom Maishman et al. · Hematological Oncology · 2017 · 17 citations · Full text

, , +17

Rows per page

1–5 of 6